Petco Health & Wellness Company, Inc. — Form 8-K
Filed September 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Petco reported Q2 2026 net sales of $1.489B (up 0.05% YoY; comparable sales +0.6%), with net income of $38.7M vs. $14.0M prior year. The company received $6.8M in net IEEPA tariff refunds and prepaid $75M in debt post-quarter (total $170M prepaid in 9 months), reducing total debt to $1.48B from $1.59B YoY. Management reaffirmed FY 2026 guidance: flat to +1.5% net sales growth and $415M–$430M Adjusted EBITDA, while targeting 2x leverage ratio.
Why this rating
Q2 results modestly positive (comps, profitability) and debt reduction favorable, but company scale ($262M market cap) means execution matters more than headlines. No material M&A, no guidance change, routine operations.
See more from September 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.